EMS Lithoclast Trilogy™: an effective single-probe dual-energy lithotripter for mini and standard PCNL
- 8 June 2019
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 38 (4) , 1043-1050
Abstract
Purpose Several energy sources are available to clear stones during PCNL. Required improvements are faster stone clearance, optimized suction and ease of use while maintaining high patient safety standard. EMS LithoClast® Trilogy, is the first device combining electromagnetic impactor with ultrasonic energy and suction, all-in-one probe. Animal studies and in vitro phantom stone studies have proven safety and efficacy of this device. We aim to study safety and clinical efficacy of Trilogy in our patients. Methods 31 patients with renal stones were included. Amplatz sheath sizes/Trilogy probe size was 22–28 Fr/10.2 Fr for standard PNL (n = 20) and 15 Fr./5.7 Fr for mini PNL access (n = 11). Analysis was done with respect to demography, stone characteristics, operation duration (total time and lithotripter activation time), post op Hb drop, clearance rate and adverse events. Stone area/volume was calculated based on CT using 3D doctor. Efficacy was determined by stone volume clearance rate (mm3/min). Results Male:female ratio was 6:5 and 16:4 for mini (MPNL)/standard PNL (SPNL). Stone densities were 1229 ± 206 vs. 1168 ± 344 HU (MPNL vs. SPNL). Mean stone volumes were 3776.1 ± 2132 mm3 for MPNL and 7096 ± 6441 for SPNL. Mean stone volume clearance ratios were 370.5 ± 171 mm3/min and 590.7 ± 250mm3/min for MPNL and SPNL, respectively. Hb drop was 1.24 ± 0.64 g/dL (MPNL) and 1.23 ± 0.89gm/dL (SPNL). Total procedure time/lithotripter activation time was 53.4 ± 23.8/14.7 ± 12.4 min for MPNL and 65.2 ± 23.5/12.0 ± 8.9 for SPNL. Immediate post-operative/1 month stone clearance rates were 93%/96% with one clinically insignificant residual fragment (< 3 mm) and no necessity for auxiliary procedures. No device failure occured and three Clavien grade I and one grade II complications were observed. Conclusion Swiss LithoClast® Trilogy provides fast stone clearance in standard/mini-PCNL procedures. Ease of use, high tissue safety and optimized suction that avoids fragment blockings are other key features.Keywords
This publication has 16 references indexed in Scilit:
- Advances in Lasers for the Treatment of Stones—a Systematic ReviewCurrent Urology Reports, 2018
- Randomized Controlled Trial Comparing Three Different Modalities of Lithotrites for Intracorporeal Lithotripsy in Percutaneous NephrolithotomyJournal of Endourology, 2017
- EAU Guidelines on Interventional Treatment for UrolithiasisEuropean Urology, 2016
- Update on lasers in urology 2014: current assessment on holmium:yttrium–aluminum–garnet (Ho:YAG) laser lithotripter settings and laser fibersWorld Journal of Urology, 2014
- Adverse Events Resulting from Lasers Used in UrologyJournal of Endourology, 2014
- What’s new in percutaneous nephrolithotomyArab Journal of Urology, 2012
- Comparison of Percutaneous Nephrolithotomy Using Pneumatic Lithotripsy (Lithoclast®) Alone or in Combination with Ultrasonic LithotripsyKorean Journal of Urology, 2010
- New Endourologic Technology for Simultaneous Holmium:YAG Laser Lithotripsy and Fragment Evacuation for PCNL: Ex-Vivo Comparison to Standard Ultrasonic LithotripsyJournal of Endourology, 2008
- High-Power Holmium:Yttrium-Aluminum-Garnet Laser for Percutaneous Treatment of Large Renal StonesUrology, 2007
- Ureteral and Bladder Lesions After Ballistic, Ultrasonic, Electrohydraulic, or Laser Lithotripsy*Journal of Endourology, 1994